Legato Capital Management LLC Has $4.81 Million Position in Intuitive Surgical, Inc. $ISRG

Legato Capital Management LLC reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.4% during the 4th quarter, Holdings Channel reports. The institutional investor owned 8,500 shares of the medical equipment provider’s stock after selling 3,200 shares during the quarter. Legato Capital Management LLC’s holdings in Intuitive Surgical were worth $4,814,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Draper Asset Management LLC increased its stake in shares of Intuitive Surgical by 41.9% during the 4th quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider’s stock worth $2,848,000 after purchasing an additional 1,485 shares during the last quarter. Atlantic Union Bankshares Corp increased its stake in shares of Intuitive Surgical by 19.3% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock worth $10,179,000 after purchasing an additional 3,676 shares during the last quarter. Valley Wealth Managers Inc. increased its stake in shares of Intuitive Surgical by 52.7% during the 3rd quarter. Valley Wealth Managers Inc. now owns 4,084 shares of the medical equipment provider’s stock worth $1,826,000 after purchasing an additional 1,409 shares during the last quarter. AGF Management Ltd. increased its stake in shares of Intuitive Surgical by 0.6% during the 3rd quarter. AGF Management Ltd. now owns 464,179 shares of the medical equipment provider’s stock worth $207,595,000 after purchasing an additional 2,575 shares during the last quarter. Finally, AE Wealth Management LLC increased its stake in shares of Intuitive Surgical by 18.9% during the 3rd quarter. AE Wealth Management LLC now owns 11,556 shares of the medical equipment provider’s stock worth $5,168,000 after purchasing an additional 1,836 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive unveiled more than 100 upcoming upgrades for its da Vinci 5 robotic surgery system, including improved force-feedback tools, telecollaboration features, and security/reliability enhancements, which could strengthen the company’s competitive moat and support future procedure growth. Intuitive Surgical’s Da Vinci 5 Upgrades Aim To Deepen Moat For Investors
• Positive Sentiment: Intuitive also announced innovations tied to its “Quintuple Aim” strategy, reinforcing product development momentum and the company’s push to improve surgeon autonomy and operating-room efficiency. Intuitive Announces Innovations to Advance Quintuple Aim
• Positive Sentiment: Wall Street commentary remains moderately optimistic, with analysts still bullish on Intuitive Surgical’s long-term prospects despite recent underperformance versus the broader market. Are Wall Street Analysts Bullish on Intuitive Surgical Stock?
• Neutral Sentiment: Investor interest continues around the SP platform, where strong procedure growth suggests an important future opportunity, but it remains unclear whether this is true addressable-market expansion or mostly a shift within existing robotic procedures. ISRG’s SP Platform: Early-Stage Growth or Next TAM Expansion Driver?
• Neutral Sentiment: There was also minor insider selling by an executive, but the transactions were very small and made under a pre-arranged 10b5-1 plan, so the signal for investors is limited. Mark Brosius insider transaction
• Negative Sentiment: The stock has also been hurt by recent weakness after earnings, with market commentary noting a roughly 7% decline since the last report, reflecting concern that the shares may need more proof of sustained acceleration. Why Is Intuitive Surgical (ISRG) Down 7.2% Since Last Earnings Report?
• Negative Sentiment: Several articles also point out that ISRG has significantly lagged the market over the past six months, which may be keeping valuation-sensitive investors on the sidelines. 3 Big Reasons ISRG Should Be On Your Watchlist

Insiders Place Their Bets

In related news, SVP Mark Brosius sold 2,362 shares of the company’s stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the transaction, the senior vice president owned 3,554 shares in the company, valued at approximately $1,772,308.72. This represents a 39.93% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Myriam Curet sold 105 shares of the company’s stock in a transaction dated Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total transaction of $51,864.75. The SEC filing for this sale provides additional information. Insiders have sold 5,701 shares of company stock worth $2,783,807 in the last 90 days. Corporate insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Truist Financial lowered their price objective on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating on the stock in a research note on Wednesday, April 15th. The Goldman Sachs Group boosted their price objective on shares of Intuitive Surgical from $609.00 to $621.00 and gave the stock a “buy” rating in a research note on Wednesday, April 22nd. Piper Sandler lowered their price objective on shares of Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. TD Cowen lowered their price objective on shares of Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Nineteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $579.33.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $438.10 on Friday. Intuitive Surgical, Inc. has a 52 week low of $417.74 and a 52 week high of $603.88. The firm has a market cap of $155.16 billion, a P/E ratio of 53.10, a price-to-earnings-growth ratio of 3.51 and a beta of 1.51. The firm’s 50-day simple moving average is $458.62 and its 200 day simple moving average is $510.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. During the same quarter in the prior year, the business earned $1.81 EPS. Intuitive Surgical’s quarterly revenue was up 23.0% on a year-over-year basis. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.